1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	development	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	flow	_	_	NN	_	_	_	_	_
5	processes	_	_	NNS	_	_	_	_	_
6	has	_	_	VBZ	_	_	_	_	_
7	gained	_	_	VBN	_	_	_	_	_
8	tremendous	_	_	JJ	_	_	_	_	_
9	interest	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	recent	_	_	JJ	_	_	_	_	_
12	years	_	_	NNS	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	organic	_	_	JJ	_	_	_	_	_
15	chemistry	_	_	NN	_	_	_	_	_
16	due	_	_	JJ	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	numerous	_	_	JJ	_	_	_	_	_
19	advantages	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	such	_	_	JJ	_	_	_	_	_
22	types	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	processes	_	_	NNS	_	_	_	_	_
25	over	_	_	IN	_	_	_	_	_
26	classic	_	_	JJ	_	_	_	_	_
27	batch	_	_	NN	_	_	_	_	_
28	approaches	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	higher	_	_	JJR	_	_	_	_	_
5	efficiency	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	safety	_	_	NN	_	_	_	_	_
8	advantages	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	ability	_	_	NN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	ensure	_	_	VB	_	_	_	_	_
14	constant	_	_	JJ	_	_	_	_	_
15	product	_	_	NN	_	_	_	_	_
16	quality	_	_	NN	_	_	_	_	_
17	has	_	_	VBZ	_	_	_	_	_
18	turned	_	_	VBN	_	_	_	_	_
19	out	_	_	RP	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	be	_	_	VB	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	major	_	_	JJ	_	_	_	_	_
24	driving	_	_	VBG	_	_	_	_	_
25	force	_	_	NN	_	_	_	_	_
26	for	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	development	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	flow	_	_	NN	_	_	_	_	_
31	processes	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	particular	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	active	_	_	JJ	_	_	_	_	_
6	pharmaceutical	_	_	JJ	_	_	_	_	_
7	ingredients	_	_	NNS	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	APIs	_	_	NNS	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	this	_	_	DT	_	_	_	_	_
13	aspect	_	_	NN	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	important	_	_	JJ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	FDA	_	_	NNP	_	_	_	_	_
20	along	_	_	RB	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	EPA	_	_	NNP	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	as	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	respective	_	_	JJ	_	_	_	_	_
28	institutions	_	_	NNS	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	United	_	_	NNP	_	_	_	_	_
31	States	_	_	NNPS	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	Europe	_	_	NNP	_	_	_	_	_
34	for	_	_	IN	_	_	_	_	_
35	approval	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	medicines	_	_	NNS	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	added	_	_	VBN	_	_	_	_	_
40	aspects	_	_	NNS	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	continuous	_	_	JJ	_	_	_	_	_
43	manufacturing	_	_	NN	_	_	_	_	_
44	to	_	_	TO	_	_	_	_	_
45	their	_	_	PRP$	_	_	_	_	_
46	guidelines	_	_	NNS	_	_	_	_	_
47	,	_	_	,	_	_	_	_	_
48	whereas	_	_	IN	_	_	_	_	_
49	for	_	_	IN	_	_	_	_	_
50	a	_	_	DT	_	_	_	_	_
51	long	_	_	JJ	_	_	_	_	_
52	time	_	_	NN	_	_	_	_	_
53	the	_	_	DT	_	_	_	_	_
54	focus	_	_	NN	_	_	_	_	_
55	of	_	_	IN	_	_	_	_	_
56	flow	_	_	NN	_	_	_	_	_
57	processes	_	_	NNS	_	_	_	_	_
58	was	_	_	VBD	_	_	_	_	_
59	on	_	_	IN	_	_	_	_	_
60	“	_	_	``	_	_	_	_	_
61	classic	_	_	JJ	_	_	_	_	_
62	”	_	_	''	_	_	_	_	_
63	chemical	_	_	JJ	_	_	_	_	_
64	processes	_	_	NNS	_	_	_	_	_
65	with	_	_	IN	_	_	_	_	_
66	,	_	_	,	_	_	_	_	_
67	for	_	_	IN	_	_	_	_	_
68	example	_	_	NN	_	_	_	_	_
69	,	_	_	,	_	_	_	_	_
70	hazardous	_	_	JJ	_	_	_	_	_
71	and	_	_	CC	_	_	_	_	_
72	thermally	_	_	RB	_	_	_	_	_
73	labile	_	_	JJ	_	_	_	_	_
74	substances	_	_	NNS	_	_	_	_	_
75	and	_	_	CC	_	_	_	_	_
76	chemocatalytic	_	_	JJ	_	_	_	_	_
77	reactions	_	_	NNS	_	_	_	_	_
78	.	_	_	.	_	_	_	_	_


1	Recently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	biocatalysis	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	flow	_	_	NN	_	_	_	_	_
6	processes	_	_	NNS	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	become	_	_	VBN	_	_	_	_	_
9	an	_	_	DT	_	_	_	_	_
10	emerging	_	_	VBG	_	_	_	_	_
11	field	_	_	NN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	an	_	_	DT	_	_	_	_	_
14	increasing	_	_	JJ	_	_	_	_	_
15	number	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	examples	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	enzymatic	_	_	JJ	_	_	_	_	_
3	reaction	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	particular	_	_	JJ	_	_	_	_	_
6	interest	_	_	NN	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	an	_	_	DT	_	_	_	_	_
9	application	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	flow	_	_	NN	_	_	_	_	_
12	mode	_	_	NN	_	_	_	_	_
13	due	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	its	_	_	PRP$	_	_	_	_	_
16	matured	_	_	JJ	_	_	_	_	_
17	technology	_	_	NN	_	_	_	_	_
18	level	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	asymmetric	_	_	JJ	_	_	_	_	_
21	ketone	_	_	NN	_	_	_	_	_
22	reduction	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	having	_	_	VBG	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	proven	_	_	VBN	_	_	_	_	_
27	track	_	_	NN	_	_	_	_	_
28	record	_	_	NN	_	_	_	_	_
29	underlined	_	_	VBN	_	_	_	_	_
30	by	_	_	IN	_	_	_	_	_
31	many	_	_	JJ	_	_	_	_	_
32	successful	_	_	JJ	_	_	_	_	_
33	examples	_	_	NNS	_	_	_	_	_
34	demonstrated	_	_	VBN	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	past	_	_	NN	_	_	_	_	_
38	for	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	batch	_	_	NN	_	_	_	_	_
41	mode	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	Recently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	significant	_	_	JJ	_	_	_	_	_
4	process	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	biocatalytic	_	_	JJ	_	_	_	_	_
8	reductive	_	_	JJ	_	_	_	_	_
9	synthesis	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	alcohols	_	_	NNS	_	_	_	_	_
12	starting	_	_	VBG	_	_	_	_	_
13	from	_	_	IN	_	_	_	_	_
14	ketones	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	as	_	_	RB	_	_	_	_	_
17	well	_	_	RB	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	syntheses	_	_	NNS	_	_	_	_	_
20	by	_	_	IN	_	_	_	_	_
21	non-enzymatic	_	_	JJ	_	_	_	_	_
22	means	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	have	_	_	VBP	_	_	_	_	_
25	been	_	_	VBN	_	_	_	_	_
26	reported	_	_	VBN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	years	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	an	_	_	DT	_	_	_	_	_
6	increasing	_	_	JJ	_	_	_	_	_
7	number	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	examples	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	biocatalysis	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	flow	_	_	NN	_	_	_	_	_
14	processes	_	_	NNS	_	_	_	_	_
15	have	_	_	VBP	_	_	_	_	_
16	been	_	_	VBN	_	_	_	_	_
17	reported	_	_	VBN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	only	_	_	RB	_	_	_	_	_
3	being	_	_	VBG	_	_	_	_	_
4	studied	_	_	VBN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	minor	_	_	JJ	_	_	_	_	_
8	extent	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	some	_	_	DT	_	_	_	_	_
11	examples	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	ketone	_	_	NN	_	_	_	_	_
14	reductions	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	an	_	_	DT	_	_	_	_	_
17	alcohol	_	_	NN	_	_	_	_	_
18	dehydrogenase	_	_	NN	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	ADH	_	_	NN	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	flow	_	_	NN	_	_	_	_	_
24	processes	_	_	NNS	_	_	_	_	_
25	have	_	_	VBP	_	_	_	_	_
26	been	_	_	VBN	_	_	_	_	_
27	described	_	_	VBN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	Wandrey	_	_	NNP	_	_	_	_	_
5	’s	_	_	POS	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	Liese	_	_	NNP	_	_	_	_	_
8	’s	_	_	POS	_	_	_	_	_
9	groups	_	_	NNS	_	_	_	_	_
10	studied	_	_	VBD	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	detail	_	_	NN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	application	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	enzyme	_	_	NN	_	_	_	_	_
17	membrane	_	_	NN	_	_	_	_	_
18	reactors	_	_	NNS	_	_	_	_	_
19	for	_	_	IN	_	_	_	_	_
20	enzymatic	_	_	JJ	_	_	_	_	_
21	ketone	_	_	NN	_	_	_	_	_
22	reduction	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	continuously	_	_	RB	_	_	_	_	_
26	running	_	_	VBG	_	_	_	_	_
27	mode	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	packed	_	_	VBN	_	_	_	_	_
31	bed	_	_	NN	_	_	_	_	_
32	reactor	_	_	NN	_	_	_	_	_
33	setups	_	_	NNS	_	_	_	_	_
34	were	_	_	VBD	_	_	_	_	_
35	described	_	_	VBN	_	_	_	_	_
36	by	_	_	IN	_	_	_	_	_
37	further	_	_	JJR	_	_	_	_	_
38	groups	_	_	NNS	_	_	_	_	_
39	using	_	_	VBG	_	_	_	_	_
40	carrier-bound	_	_	JJ	_	_	_	_	_
41	ADH	_	_	NN	_	_	_	_	_
42	from	_	_	IN	_	_	_	_	_
43	Lactobacillus	_	_	NNP	_	_	_	_	_
44	brevis	_	_	NNP	_	_	_	_	_
45	(	_	_	-LRB-	_	_	_	_	_
46	LB-ADH	_	_	NN	_	_	_	_	_
47	)	_	_	-RRB-	_	_	_	_	_
48	in	_	_	IN	_	_	_	_	_
49	combination	_	_	NN	_	_	_	_	_
50	with	_	_	IN	_	_	_	_	_
51	a	_	_	DT	_	_	_	_	_
52	mobile	_	_	JJ	_	_	_	_	_
53	aqueous	_	_	JJ	_	_	_	_	_
54	phase	_	_	NN	_	_	_	_	_
55	,	_	_	,	_	_	_	_	_
56	or	_	_	CC	_	_	_	_	_
57	magnetic	_	_	JJ	_	_	_	_	_
58	nanoparticle-bound	_	_	NN	_	_	_	_	_
59	ADH	_	_	NN	_	_	_	_	_
60	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	Buehler	_	_	NNP	_	_	_	_	_
5	et	_	_	FW	_	_	_	_	_
6	al.	_	_	FW	_	_	_	_	_


1	investigated	_	_	VBD	_	_	_	_	_
2	intensively	_	_	RB	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	use	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	ADH	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	aqueous/organic	_	_	JJ	_	_	_	_	_
9	segmented	_	_	VBN	_	_	_	_	_
10	flow	_	_	NN	_	_	_	_	_
11	systems	_	_	NNS	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	shown	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	emulsion	_	_	NN	_	_	_	_	_
6	formation	_	_	NN	_	_	_	_	_
7	could	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	eliminated	_	_	VBN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	enzymatic	_	_	JJ	_	_	_	_	_
13	mass	_	_	NN	_	_	_	_	_
14	transfer-limited	_	_	VBN	_	_	_	_	_
15	reactions	_	_	NNS	_	_	_	_	_
16	can	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	enhanced	_	_	VBN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	different	_	_	JJ	_	_	_	_	_
4	means	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	stabilization	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	this	_	_	DT	_	_	_	_	_
9	reaction	_	_	NN	_	_	_	_	_
10	system	_	_	NN	_	_	_	_	_
11	were	_	_	VBD	_	_	_	_	_
12	investigated	_	_	VBN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Very	_	_	RB	_	_	_	_	_
2	recently	_	_	RB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	our	_	_	PRP$	_	_	_	_	_
5	group	_	_	NN	_	_	_	_	_
6	published	_	_	VBD	_	_	_	_	_
7	an	_	_	DT	_	_	_	_	_
8	improved	_	_	VBN	_	_	_	_	_
9	downstream	_	_	JJ	_	_	_	_	_
10	process	_	_	NN	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	means	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	such	_	_	PDT	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	segmented	_	_	VBN	_	_	_	_	_
17	flow	_	_	NN	_	_	_	_	_
18	process	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	illustrated	_	_	VBN	_	_	_	_	_
21	using	_	_	VBG	_	_	_	_	_
22	two	_	_	CD	_	_	_	_	_
23	different	_	_	JJ	_	_	_	_	_
24	ADHs	_	_	NNS	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	substrates	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	continuous	_	_	JJ	_	_	_	_	_
3	processes	_	_	NNS	_	_	_	_	_
4	using	_	_	VBG	_	_	_	_	_
5	packed	_	_	JJ	_	_	_	_	_
6	bed	_	_	NN	_	_	_	_	_
7	reactors	_	_	NNS	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	PBR	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	catalyst	_	_	NN	_	_	_	_	_
13	immobilization	_	_	NN	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	prerequisite	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Also	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	downstream	_	_	JJ	_	_	_	_	_
4	processes	_	_	NNS	_	_	_	_	_
5	benefit	_	_	VBP	_	_	_	_	_
6	from	_	_	IN	_	_	_	_	_
7	immobilization	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	as	_	_	IN	_	_	_	_	_
10	separation	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	reaction	_	_	NN	_	_	_	_	_
14	mixture	_	_	NN	_	_	_	_	_
15	from	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	catalyst	_	_	NN	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	easier	_	_	JJR	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	catalyst	_	_	NN	_	_	_	_	_
24	reusability	_	_	NN	_	_	_	_	_
25	is	_	_	VBZ	_	_	_	_	_
26	improved	_	_	VBN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	both	_	_	DT	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	operational	_	_	JJ	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	as	_	_	RB	_	_	_	_	_
8	well	_	_	RB	_	_	_	_	_
9	as	_	_	IN	_	_	_	_	_
10	storage	_	_	NN	_	_	_	_	_
11	stability	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	catalyst	_	_	NN	_	_	_	_	_
15	can	_	_	MD	_	_	_	_	_
16	potentially	_	_	RB	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	significantly	_	_	RB	_	_	_	_	_
19	increased	_	_	VBN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	often	_	_	RB	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	significant	_	_	JJ	_	_	_	_	_
6	loss	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	enzymatic	_	_	JJ	_	_	_	_	_
9	activity	_	_	NN	_	_	_	_	_
10	during	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	immobilization	_	_	NN	_	_	_	_	_
13	process	_	_	NN	_	_	_	_	_
14	represents	_	_	VBZ	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	drawback	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	reproducible	_	_	JJ	_	_	_	_	_
21	production	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	immobilized	_	_	VBN	_	_	_	_	_
24	catalyst	_	_	NN	_	_	_	_	_
25	may	_	_	MD	_	_	_	_	_
26	be	_	_	VB	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	further	_	_	JJR	_	_	_	_	_
29	challenge	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Numerous	_	_	JJ	_	_	_	_	_
2	techniques	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	developed	_	_	VBN	_	_	_	_	_
6	over	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	past	_	_	JJ	_	_	_	_	_
9	years	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	can	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	classified	_	_	VBN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	following	_	_	VBG	_	_	_	_	_
18	three	_	_	CD	_	_	_	_	_
19	major	_	_	JJ	_	_	_	_	_
20	methods	_	_	NNS	_	_	_	_	_
21	:	_	_	:	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	a	_	_	NN	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	binding	_	_	NN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	solid	_	_	JJ	_	_	_	_	_
29	support	_	_	NN	_	_	_	_	_
30	(	_	_	-LRB-	_	_	_	_	_
31	carrier	_	_	NN	_	_	_	_	_
32	)	_	_	-RRB-	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	(	_	_	-LRB-	_	_	_	_	_
35	b	_	_	NN	_	_	_	_	_
36	)	_	_	-RRB-	_	_	_	_	_
37	entrapment	_	_	NN	_	_	_	_	_
38	(	_	_	-LRB-	_	_	_	_	_
39	encapsulation	_	_	NN	_	_	_	_	_
40	)	_	_	-RRB-	_	_	_	_	_
41	in	_	_	IN	_	_	_	_	_
42	polymer	_	_	NN	_	_	_	_	_
43	networks	_	_	NNS	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	or	_	_	CC	_	_	_	_	_
46	(	_	_	-LRB-	_	_	_	_	_
47	c	_	_	NN	_	_	_	_	_
48	)	_	_	-RRB-	_	_	_	_	_
49	cross-linking	_	_	NN	_	_	_	_	_
50	in	_	_	IN	_	_	_	_	_
51	the	_	_	DT	_	_	_	_	_
52	form	_	_	NN	_	_	_	_	_
53	of	_	_	IN	_	_	_	_	_
54	cross-linked	_	_	JJ	_	_	_	_	_
55	enzyme	_	_	NN	_	_	_	_	_
56	aggregates	_	_	NNS	_	_	_	_	_
57	(	_	_	-LRB-	_	_	_	_	_
58	CLEAs	_	_	NNP	_	_	_	_	_
59	)	_	_	-RRB-	_	_	_	_	_
60	or	_	_	CC	_	_	_	_	_
61	cross-linked	_	_	JJ	_	_	_	_	_
62	enzyme	_	_	NN	_	_	_	_	_
63	crystals	_	_	NNS	_	_	_	_	_
64	(	_	_	-LRB-	_	_	_	_	_
65	CLECs	_	_	NNS	_	_	_	_	_
66	)	_	_	-RRB-	_	_	_	_	_
67	.	_	_	.	_	_	_	_	_


1	Recently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	much	_	_	JJ	_	_	_	_	_
4	progress	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	field	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	enzyme	_	_	NN	_	_	_	_	_
10	immobilization	_	_	NN	_	_	_	_	_
11	has	_	_	VBZ	_	_	_	_	_
12	been	_	_	VBN	_	_	_	_	_
13	made	_	_	VBN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	work	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	option	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	entrapment	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	enzymes	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	polymer	_	_	NN	_	_	_	_	_
13	networks	_	_	NNS	_	_	_	_	_
14	has	_	_	VBZ	_	_	_	_	_
15	been	_	_	VBN	_	_	_	_	_
16	chosen	_	_	VBN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Often	_	_	RB	_	_	_	_	_
2	for	_	_	IN	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	purpose	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	organic	_	_	JJ	_	_	_	_	_
7	polymers	_	_	NNS	_	_	_	_	_
8	containing	_	_	VBG	_	_	_	_	_
9	cavities	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	sol-gel-processed	_	_	JJ	_	_	_	_	_
12	particles	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	membranes	_	_	NNS	_	_	_	_	_
16	are	_	_	VBP	_	_	_	_	_
17	used	_	_	VBN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	special	_	_	JJ	_	_	_	_	_
3	case	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	use	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	superabsorbent	_	_	JJ	_	_	_	_	_
9	polymers	_	_	NNS	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	immobilize	_	_	VB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	entire	_	_	JJ	_	_	_	_	_
14	aqueous	_	_	JJ	_	_	_	_	_
15	phase.	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	case	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	enzyme	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	immobilized	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	its	_	_	PRP$	_	_	_	_	_
11	native	_	_	JJ	_	_	_	_	_
12	aqueous	_	_	JJ	_	_	_	_	_
13	environment	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	whereby	_	_	IN	_	_	_	_	_
16	undesired	_	_	JJ	_	_	_	_	_
17	interactions	_	_	NNS	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	protein	_	_	NN	_	_	_	_	_
20	moieties	_	_	NNS	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	support	_	_	NN	_	_	_	_	_
24	can	_	_	MD	_	_	_	_	_
25	be	_	_	VB	_	_	_	_	_
26	prevented	_	_	VBN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Recently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	Gröger	_	_	NNP	_	_	_	_	_
4	et	_	_	FW	_	_	_	_	_
5	al.	_	_	FW	_	_	_	_	_
6	applied	_	_	VBD	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	method	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	immobilizing	_	_	VBG	_	_	_	_	_
11	ADHs	_	_	NNS	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	superabsorber	_	_	NN	_	_	_	_	_
14	efficiently	_	_	RB	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	synthesis	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	diols	_	_	NNS	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	enantiomerically	_	_	RB	_	_	_	_	_
22	pure	_	_	JJ	_	_	_	_	_
23	form	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	example	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	immobilized	_	_	VBN	_	_	_	_	_
7	ADH	_	_	NNP	_	_	_	_	_
8	from	_	_	IN	_	_	_	_	_
9	Rhodococcus	_	_	NNP	_	_	_	_	_
10	sp	_	_	NNP	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	used	_	_	VBN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	organic	_	_	JJ	_	_	_	_	_
16	solvents	_	_	NNS	_	_	_	_	_
17	without	_	_	IN	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	major	_	_	JJ	_	_	_	_	_
20	loss	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	activity	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Advantages	_	_	NNS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	method	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	low	_	_	JJ	_	_	_	_	_
8	cost	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	very	_	_	RB	_	_	_	_	_
12	fast	_	_	JJ	_	_	_	_	_
13	immobilization	_	_	NN	_	_	_	_	_
14	procedure	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	<30	_	_	CD	_	_	_	_	_
17	min	_	_	NNS	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	excellent	_	_	JJ	_	_	_	_	_
23	catalyst	_	_	NN	_	_	_	_	_
24	reusability	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Challenging	_	_	VBG	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	particular	_	_	JJ	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	respect	_	_	NN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	an	_	_	DT	_	_	_	_	_
9	application	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	fixed	_	_	VBN	_	_	_	_	_
13	bed	_	_	NN	_	_	_	_	_
14	reactor	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	might	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	gel-like	_	_	JJ	_	_	_	_	_
20	consistency	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	hydrogel	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	mass	_	_	NN	_	_	_	_	_
26	transfer	_	_	NN	_	_	_	_	_
27	limitations	_	_	NNS	_	_	_	_	_
28	through	_	_	IN	_	_	_	_	_
29	phase	_	_	NN	_	_	_	_	_
30	interfaces	_	_	NNS	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	general	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	absorbent	_	_	JJ	_	_	_	_	_
3	polymer	_	_	NN	_	_	_	_	_
4	consists	_	_	VBZ	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	cross-linked	_	_	JJ	_	_	_	_	_
7	polyacrylic	_	_	JJ	_	_	_	_	_
8	acid	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	which	_	_	WDT	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	partially	_	_	RB	_	_	_	_	_
13	neutralized	_	_	VBN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Proteins	_	_	NNS	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	embedded	_	_	VBN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	this	_	_	DT	_	_	_	_	_
7	polymer	_	_	NN	_	_	_	_	_
8	matrix	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	can	_	_	MD	_	_	_	_	_
11	be	_	_	VB	_	_	_	_	_
12	bound	_	_	VBN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	example	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	by	_	_	IN	_	_	_	_	_
18	ionic	_	_	JJ	_	_	_	_	_
19	interactions	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	its	_	_	PRP$	_	_	_	_	_
22	acid	_	_	NN	_	_	_	_	_
23	moieties	_	_	NNS	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	ionic	_	_	JJ	_	_	_	_	_
26	amino	_	_	NN	_	_	_	_	_
27	acid	_	_	NN	_	_	_	_	_
28	residues	_	_	NNS	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	protein	_	_	NN	_	_	_	_	_
32	(	_	_	-LRB-	_	_	_	_	_
33	see	_	_	VB	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	1	_	_	CD	_	_	_	_	_


1	A	_	_	NN	_	_	_	_	_
2	)	_	_	-RRB-	_	_	_	_	_
3	.	_	_	.	_	_	_	_	_
4	Also	_	_	RB	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	hydrogen	_	_	NN	_	_	_	_	_
7	bridges	_	_	NNS	_	_	_	_	_
8	from	_	_	IN	_	_	_	_	_
9	non-ionic	_	_	JJ	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	residues	_	_	NNS	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	superabsorber	_	_	NN	_	_	_	_	_
14	functionalities	_	_	NNS	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	1	_	_	CD	_	_	_	_	_


1	B	_	_	NN	_	_	_	_	_
2	)	_	_	-RRB-	_	_	_	_	_
3	or	_	_	CC	_	_	_	_	_
4	entrapment	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	enzyme	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	superabsorber-bound	_	_	JJ	_	_	_	_	_
9	water	_	_	NN	_	_	_	_	_
10	residues	_	_	NNS	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	1	_	_	CD	_	_	_	_	_


1	C	_	_	NNP	_	_	_	_	_
2	)	_	_	-RRB-	_	_	_	_	_
3	can	_	_	MD	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	possible	_	_	JJ	_	_	_	_	_
7	mode	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	interaction	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	R	_	_	NN	_	_	_	_	_
4	)-enantioselective	_	_	NN	_	_	_	_	_
5	ADH	_	_	NN	_	_	_	_	_
6	from	_	_	IN	_	_	_	_	_
7	Lactobacillus	_	_	NNP	_	_	_	_	_
8	brevis	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	LB-ADH	_	_	NNP	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	has	_	_	VBZ	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	shown	_	_	VBN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	versatile	_	_	JJ	_	_	_	_	_
19	catalyst	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	reduction	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	variety	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	ketones	_	_	NNS	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	ranging	_	_	VBG	_	_	_	_	_
30	from	_	_	IN	_	_	_	_	_
31	aliphatic	_	_	JJ	_	_	_	_	_
32	ketones	_	_	NNS	_	_	_	_	_
33	to	_	_	TO	_	_	_	_	_
34	benzylic	_	_	JJ	_	_	_	_	_
35	or	_	_	CC	_	_	_	_	_
36	propargylic	_	_	JJ	_	_	_	_	_
37	ketones	_	_	NNS	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	used	_	_	VBN	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	an	_	_	DT	_	_	_	_	_
7	isolated	_	_	VBN	_	_	_	_	_
8	enzyme	_	_	NN	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	whole-cell	_	_	JJ	_	_	_	_	_
13	catalyst	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	particular	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	its	_	_	PRP$	_	_	_	_	_
5	tolerance	_	_	NN	_	_	_	_	_
6	towards	_	_	IN	_	_	_	_	_
7	organic	_	_	JJ	_	_	_	_	_
8	solvents	_	_	NNS	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	outstanding	_	_	JJ	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	stability	_	_	NN	_	_	_	_	_
3	depends	_	_	VBZ	_	_	_	_	_
4	on	_	_	IN	_	_	_	_	_
5	several	_	_	JJ	_	_	_	_	_
6	factors	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	such	_	_	JJ	_	_	_	_	_
9	as	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	nature	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	buffer	_	_	NN	_	_	_	_	_
15	or	_	_	CC	_	_	_	_	_
16	solvent	_	_	JJ	_	_	_	_	_
17	additives	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	contribution	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	application	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	superabsorber-immobilized	_	_	JJ	_	_	_	_	_
10	ADH	_	_	NN	_	_	_	_	_
11	from	_	_	IN	_	_	_	_	_
12	L.	_	_	NNP	_	_	_	_	_
13	brevis	_	_	FW	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	an	_	_	DT	_	_	_	_	_
16	enzymatic	_	_	JJ	_	_	_	_	_
17	reduction	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	acetophenone	_	_	NN	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	1	_	_	CD	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	flow	_	_	NN	_	_	_	_	_
26	process	_	_	NN	_	_	_	_	_
27	is	_	_	VBZ	_	_	_	_	_
28	described	_	_	VBN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_

